Zolmitriptan stimulates a Ca2+-dependent K+ current in C6 glioma cells stably expressing recombinant human 5-HT(1B) receptors

European Journal of Pharmacology

Volumn 397, Issue 2-3, 2000, Pages 297-302

  Le Grand, Bruno ^a   Panissié, Anne ^a   Perez, Michel ^a   Pauwels, Petrus J ^a   John, Gareth W ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

5 HT(1B) receptor; C6 glioma cell; Ca2+ dependent; human; K+ channel; Zolmitriptan

Indexed keywords

IBERIOTOXIN; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN 1B RECEPTOR; TETRYLAMMONIUM; ZOLMITRIPTAN;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GLIOMA CELL; HYPERPOLARIZATION; MIGRAINE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; TRIGEMINUS GANGLION;

ANIMALS; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MEMBRANE POTENTIALS; OXADIAZOLES; OXAZOLES; OXAZOLIDINONES; PEPTIDES; PIPERAZINES; POTASSIUM CHANNELS; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; RECOMBINANT FUSION PROTEINS; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TETRAETHYLAMMONIUM; TRYPTAMINES; TUMOR CELLS, CULTURED;

EID: 0034595760     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00284-3     Document Type: Article

References (24)

1. Bouchelet I., Cohen ZV.I., Case B., Seguéla P., Hamel E. Differential expression of sumatriptan sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol. Pharmacol. 50:1996;219-223.
2. 1B receptor messenger mRNA in neurones of the trigeminal ganglia. Eur. J. Pharmacol. 227:1992;357-359.
3. 1D antagonists. J. Med. Chem. 37:1994;2253-2257.
4. Elliot J.M., Newberry N.R., Cholewinski A.J., Bartrup J.T., Briddon S.J., Carey J.E., Flanigan T.P., Newton R.A., Phipps S.L., Reavley A.C., Smith C., Wigmore M., Grahame-Smith D.G., Leslie R.A. Characterization of the 5-hydroxytryptamine 2A receptor activated cascade in rat C6 glioma cells. Neuroscience. 69:1995;1119-1131.
5. Goadsby P.J., Edvinsson L. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5-HT)-1D receptor agonist zolmitriptan. Headache. 34:1994;394-399.
6. 1B/1D receptor agonist 311C90 (zolmitriptan). Are brainstem sites a therapeutic target in migraine? Pain. 67:1996;355-359.
7. Goadsby P.J., Knight Y. Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat. Cephalalgia. 17:1997;153-158.
8. Goadsby P.J., Zagami A.S., Lambert G.A. Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine. Headache. 31:1991;365-371.
9. 2+ stores. Nature. 372:1994;791-794.
10. Hoskin K.L., Kaube H., Goadsby P.J. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain. 119:1996;1419-1428.
11. 1B/1D receptors in models relevant to migraine. J. Pharmacol. Exp. Ther. 290:1999;83-95.
12. Kobayashi S., Somlyo A.V., Somlyo A.P. Heparin inhibits the inositol 1,4,5-triphosphate-dependent, but not the independent calcium release induced by guanine nucleotide in vascular smooth muscle. Biochem. Biophys. Res. Commun. 153:1988;625-631.
13. + current. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;608-615.
14. 1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalagia. 17:1997;833-842.
15. Manor D., Moran N., Segal M. Calcium dependence of serotonin-evoked conductance in C6 glioma cells. Glia. 6:1992;118-126.
16. 1D agonists drugs: selectively targeting additional sites of action. Eur. Neurol. 36(Suppl. 2):1996;13-18.
17. 1B/1D receptor partial agonist, 311C90 (zolmitriptan). Br. J. Pharmacol. 121:1997;157-164.
18. Moskowitz M.A. The neurobiology of vascular head pain. Ann. Neurol. 16:1984;157-168.
19. 1B receptors. Naunyn-Schmiedebergs Arch. Pharmacol. 353:1996;144-156.
20. 1B/1D receptor ligands: an answer from GTPγS binding studies with stably transfected C6-glial cell lines. Neuropharmacology. 36:1997;499-512.
21. 1B receptor. Br. J. Pharmacol. 123:1998;51-62.
22. + currents in neurones: types, physiological roles and modulation. Trends Neurosci. 19:1996;150-154.
23. 1B/1D receptor agonist zolmitriptan on motor cortical excitability in humans. Neurology. 51:1998;896-898.
24. Xia X.-M., Fakler B., Rivard A., Wayman G., Johnson-Pais T., Keen J.E., Ishii T., Hirschberg B., Bond C.T., Lutsenko S., Maylie J., Adelman J.P. Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature. 395:1998;503-507.